Search
Descriptor English: Ki-1 Antigen
Descriptor Spanish: Antígeno Ki-1
Descriptor antígeno Ki-1
Entry term(s) antígeno Ber H2
antígeno Ber-H2
antígeno CD30
antígeno Ki 1
antígenos Ber H2
antígenos Ber-H2
antígenos CD30
antígenos Ki 1
antígenos Ki-1
miembro 8 de la superfamilia de receptores del factor de necrosis tumoral
receptores TNFRSF8
Scope note: Miembro de la superfamilia de receptores de factores de necrosis tumoral que interviene en la regulación del NF-KAPPA B y la apoptosis. Se encuentra en células activadas tales como LINFOCITOS T, LINFOCITOS B, NEUTRÓFILOS, EOSINÓFILOS, MASTOCITOS y CÉLUAS ASESINAS NATURALES (CÉLULAS NK). La sobreexpresión del antígeno CD30 en los tumores malignos hematopoyéticos hace que este antígeno sea clínicamente útil como marcador biológico tumoral. Este receptor se torna señalizador cuando se asocia con FACTORES ASOCIADOS A RECEPTORES DE TNF.
Descriptor Portuguese: Antígeno Ki-1
Descriptor French: Antigènes CD30
Entry term(s): Antigen, Ber-H2
Antigen, CD30
Antigen, Ki-1
Antigens, Ber-H2
Antigens, CD30
Antigens, Ki 1
Antigens, Ki-1
Ber H2 Antigen
Ber H2 Antigens
Ber-H2 Antigen
Ber-H2 Antigens
CD30 Antigen
CD30 Antigens
Ki 1 Antigen
Ki 1 Antigens
Ki-1 Antigens
Receptor, TNFRSF8
TNFRSF8 Receptor
Tumor Necrosis Factor Receptor Superfamily, Member 8
Tree number(s): D12.776.543.750.705.852.760.072
D23.050.285.025
D23.101.140.055
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D017730
Scope note: A member of the tumor necrosis factor receptor superfamily that may play a role in the regulation of NF-KAPPA B and APOPTOSIS. It is found on activated T-LYMPHOCYTES; B-LYMPHOCYTES; NEUTROPHILS; EOSINOPHILS; MAST CELLS and NK CELLS. Overexpression of the Ki-1 antigen in hematopoietic malignancies make it clinically useful as a biological tumor marker. Signaling of the receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.
Allowable Qualifiers: AD administration & dosage
AG agonists
AI antagonists & inhibitors
AN analysis
BI biosynthesis
BL blood
CH chemistry
CL classification
DE drug effects
DF deficiency
GE genetics
HI history
IM immunology
IP isolation & purification
ME metabolism
PH physiology
RE radiation effects
TU therapeutic use
UL ultrastructure
Previous Indexing: Antigens, CD (1990-1993)
Antigens, Differentiation (1988-1993)
Antigens, Neoplasm (1985-1993)
Public MeSH Note: 2018; see ANTIGENS, CD30 1994-2017 and CD30 ANTIGEN 1983-93
History Note: 2018 (1983)
DeCS ID: 31645
Unique ID: D017730
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1994/01/01
Date of Entry: 1992/12/28
Revision Date: 2017/05/24
Ki-1 Antigen - Preferred
Concept UI M0026795
Scope note A member of the tumor necrosis factor receptor superfamily that may play a role in the regulation of NF-KAPPA B and APOPTOSIS. It is found on activated T-LYMPHOCYTES; B-LYMPHOCYTES; NEUTROPHILS; EOSINOPHILS; MAST CELLS and NK CELLS. Overexpression of the Ki-1 antigen in hematopoietic malignancies make it clinically useful as a biological tumor marker. Signaling of the receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.
Preferred term Ki-1 Antigen
Entry term(s) Antigen, Ber-H2
Antigen, CD30
Antigen, Ki-1
Antigens, Ber-H2
Antigens, CD30
Antigens, Ki 1
Antigens, Ki-1
Ber H2 Antigen
Ber H2 Antigens
Ber-H2 Antigen
Ber-H2 Antigens
CD30 Antigen
CD30 Antigens
Ki 1 Antigen
Ki 1 Antigens
Ki-1 Antigens
Receptor, TNFRSF8
TNFRSF8 Receptor
Tumor Necrosis Factor Receptor Superfamily, Member 8



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey